AsCNP/JSNP/JSCNP 2019

Presentation information

Print

[AsCNP] Poster Session

AsCNP » [AsCNP] Poster Session

[AsCNP_DDR] Poster Session for Symposium-40
Noteworthy drug discovery/research and development - Aiming for innovation -

Sun. Oct 13, 2019 4:40 PM - 6:10 PM Poster Hall (Multi-purpose Hall)

Chair: ‌Tetsurou KIKUCHI (New Drug Research Division, Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd.)

*Posters of this session will be displayed for three days from October 11 (Fri) to October 13 (Sun).

4:50 PM - 4:55 PM

[AsCNP-DDR-3] SEP-363856, a Candidate Antipsychotic Compound with a Novel Non-D2 Mechanism of Action

○Kazuki YABUUCHI1, Kenneth KOBLAN2, Robert GOLDMAN2, Justine KENT2, Seth HOPKINS2, Antony LOBEL2 (1. Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceutical Inc.)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password